Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article April 21 2025
Coordinated regulation of self-renewal and cell cycle during human lympho-myeloid lineage restriction
Research Article April 21 2025
Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of 'Super' transplantability
Research Article April 21 2025
Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysis
Research Article April 21 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
Research Article April 16 2025
Genotype-specific immune responses at the intestinal barrier predispose to colitis in chronic granulomatous disease in mice
Review Article April 16 2025
International Consensus Statement on Diagnosis, Evaluation, and Research of Richter Transformation: the ERIC Recommendations
Review Article April 16 2025
How I individualize treatment for chronic-phase CML
Review Article April 15 2025
The evolving landscape of hereditary stomatocytosis
Research Article April 15 2025
Outcomes of PLAT-02 and PLAT-03: Evaluating CD19 CAR T-Cell Therapy and CD19-expressing T-APC Support in Pediatric B-ALL
Research Article April 15 2025
The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy
Letter April 15 2025
DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera
Letter April 15 2025
Maternal Tmprss6 is required for hepcidin suppression and fetal health
Review Article April 15 2025
Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practice
Review Article April 10 2025
Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukaemia.
Review Article April 10 2025
How I Treat Wiskott-Aldrich syndrome
Brief Report April 10 2025
ZUMA-8: A Phase 1 Study of Brexucabtagene Autoleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Research Article April 10 2025
An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells
Research Article April 8 2025
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up
Research Article April 8 2025
Standard-of-Care Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis
Research Article April 8 2025
Acalabrutinib-Obinutuzumab Improves Survival vs Chemoimmunotherapy in treatment-naive CLL in the 6-year Follow-up of ELEVATE-TN
Research Article April 7 2025
Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia
Research Article April 7 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
Research Article April 3 2025
Blood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML Outcomes
Research Article April 1 2025
Diagnostic BRAFV600E blood predicts treatment failure and neurodegeneration and redefines paradigms of pediatric LCH
Research Article March 31 2025
Relationship between Immunogenicity and Protein Structure at Amino Acid Substitution Sites of Blood Group Antigens
Research Article March 31 2025
Iron overload in HFE-related hemochromatosis severely impairs Vδ2 γδ T-cell homeostasis
Brief Report March 31 2025
Cell-autonomous dysregulation of interferon signaling drives clonal expansion of SRSF2-mutant MDS stem/progenitor cells
Research Article March 31 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AML
Letter March 31 2025
Cyclophosphamide mitigates non-ICANS neurotoxicities after ciltacabtagene autoleucel treatment
Research Article March 31 2025
Hallmarks of terminal T-cell exhaustion are absent in multiple myeloma from diagnosis through maintenance therapy
Research Article March 31 2025
IFN-γ promotes the progression of iMCD by activating inflammatory monocytes
Research Article March 27 2025
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
Research Article March 25 2025
Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the lifespan
Review Article March 25 2025
Structure-based design of therapeutics to control hemostasis
Research Article March 25 2025
Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia
Review Article March 25 2025
How I treat chronic myeloid leukemia in children and adolescents
Brief Report March 25 2025
NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation
Review Article March 25 2025
Metabolic Pathways in Deep Vein Thrombosis: A New Frontier for Therapeutic Intervention
Research Article March 24 2025
Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results
Research Article March 20 2025
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes
Letter March 20 2025
Diabetes Mellitus and APOL1 Genotype Increase the Risk for Chronic Kidney Disease Progression in Sickle Cell Disease
Research Article March 19 2025
NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma
Review Article March 19 2025
PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target
Review Article March 19 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
Brief Report March 19 2025
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
Letter March 18 2025
Prognostic Biomarkers in MCL: Insights from the SHINE Trial on the impact of MCL35 score and TP53 Mutation Status
Brief Report March 18 2025
Enhanced α2-3 linked sialylation determines the extended half-life of CHO-rVWF
Discussion March 18 2025
Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter?
Letter March 18 2025
STAT1-mediated interferon signatures associate with preclinical JAK-inhibitor sensitivity in T-cell acute lymphoblastic leukemia
Brief Report March 16 2025
The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes Csa/Csb red cell antigens
Page 1 of 4
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals